Betty Liu
Ph.D. Student in Bioengineering, admitted Autumn 2020
Education & Certifications
-
Master of Science, Stanford University, BIOE-MS (2022)
-
B.A.Sc. (HH), University of Toronto, Engineering Science - Biomedical Systems Engineering Option (2020)
All Publications
-
Engineered cell entry links receptor biology with single-cell genomics.
Cell
2022
Abstract
Cells communicate with each other via receptor-ligand interactions. Here, we describe lentiviral-mediated cell entry by engineered receptor-ligand interaction (ENTER) to display ligand proteins, deliver payloads, and record receptor specificity. We optimize ENTER to decode interactions between Tcell receptor (TCR)-MHC peptides, antibody-antigen, and other receptor-ligand pairs. A viral presentation strategy allows ENTER to capture interactions between B cell receptor and any antigen. We engineer ENTER to deliver genetic payloads to antigen-specific T or B cells to selectively modulate cellular behavior in mixed populations. Single-cell readout of ENTER by RNA sequencing (ENTER-seq) enables multiplexed enumeration of antigen specificities, TCR clonality, cell type, and states of individual Tcells. ENTER-seq of CMV-seropositive patient blood samples reveals the viral epitopes that drive effector memory Tcell differentiation and inter-clonal vs. intra-clonal phenotypic diversity targeting the same epitope. ENTER technology enables systematic discovery of receptor specificity, linkage to cell fates, and antigen-specific cargo delivery.
View details for DOI 10.1016/j.cell.2022.11.016
View details for PubMedID 36516854